Literature DB >> 6440191

The effect of adrenalectomy and dexamethasone on the antinociceptive effects of physostigmine.

J A Romano, T M Shih.   

Abstract

The tail-flick procedure was used to study the antinociceptive effects of physostigmine in adrenalectomized and sham-operated rats. At 5 days after surgery, they were tested 30 min after either 0.32 or 0.45 mg/kg IP physostigmine. Adrenalectomized animals showed significantly greater elevation of TF scores from predrug latencies than the sham controls at both doses of physostigmine. Following 3 days of dexamethasone replacement therapy on days 18, 19, and 20 post-surgery the antinociceptive effects of physostigmine were uniformly attenuated across doses or surgical groups. On the other hand, animals receiving saline injection instead of dexamethasone did not manifest any reduction of the physostigmine antinociceptive effect. The potentiation by adrenalectomy and the reduction following dexamethasone of the antinociceptive effects of physostigmine suggest that these effects may be mediated through hypothalamic-pituitary-adrenal mechanisms and are consistent with beta-endorphin-induced sensitization of opiate or cholinergic receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440191     DOI: 10.1007/bf00555226

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Some relationships between effects of insecticides and other stress conditions.

Authors:  S D Murphy
Journal:  Ann N Y Acad Sci       Date:  1969       Impact factor: 5.691

2.  Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray.

Authors:  T L Yaksh
Journal:  Brain Res       Date:  1979-01-05       Impact factor: 3.252

3.  Brain acetylcholine levels and inhibition of the tail-flick reflex in mice.

Authors:  J F Howes; L S Harris; W L Dewey; C A Voyda
Journal:  J Pharmacol Exp Ther       Date:  1969-09       Impact factor: 4.030

4.  Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans.

Authors:  S C Risch; D S Janowsky; L J Siever; L J Judd; J L Rausch; L Y Huey; K A Beckman; R M Cohen; D L Murphy
Journal:  Peptides       Date:  1982 May-Jun       Impact factor: 3.750

5.  Effect of peripheral cholinergic activation on the adrenal cortex function.

Authors:  M G Kolta; K F Soliman
Journal:  Endocr Res Commun       Date:  1981

6.  Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.

Authors:  K Jhamandas; M Sutak
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  Degree of inhibition of ACTH release by glucocorticoids in adrenalectomized rats.

Authors:  M Sakakura; M Yoshioka; M Kobayashi; K Takebe
Journal:  Neuroendocrinology       Date:  1981-01       Impact factor: 4.914

8.  Cholinergic mechanisms of analgesia produced by physostigmine, morphine and cold water swimming.

Authors:  J A Romano; T M Shih
Journal:  Neuropharmacology       Date:  1983-07       Impact factor: 5.250

9.  Di-isopropyl phosphofluoridate-induced antinociception: possible role of endogenous opioids.

Authors:  G L Koehn; G Henderson; A G Karczmar
Journal:  Eur J Pharmacol       Date:  1980-01-25       Impact factor: 4.432

10.  Comparison of the antinociceptive activity of intraventricularly administered acetylcholine to narcotic antinociception.

Authors:  N W Pedigo; W L Dewey
Journal:  Neurosci Lett       Date:  1981-10       Impact factor: 3.046

View more
  1 in total

1.  Environmental influences on the development of tolerance to the effects of physostigmine on schedule-controlled behavior.

Authors:  R F Genovese; T F Elsmore; J M Witkin
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.